vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Forestar Group Inc. (FOR). Click either name above to swap in a different company.
Forestar Group Inc. is the larger business by last-quarter revenue ($273.0M vs $185.2M, roughly 1.5× AMICUS THERAPEUTICS, INC.). Forestar Group Inc. runs the higher net margin — 5.6% vs 0.9%, a 4.7% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 9.0%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $-157.1M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -9.6%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Forestar Group Inc. is a residential lot development company based in Arlington, Texas. The company has operations in 51 markets in 21 states and delivered 11,518 residential lots during the twelve-month period ended December 31, 2020. The company is publicly traded on the New York Stock Exchange and in October 2017 became a majority-owned subsidiary of D.R. Horton, Inc., the largest homebuilder by volume in the United States since 2002. The company primarily acquires entitled real estate and...
FOLD vs FOR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $273.0M |
| Net Profit | $1.7M | $15.4M |
| Gross Margin | 85.7% | 20.1% |
| Operating Margin | 8.6% | 7.6% |
| Net Margin | 0.9% | 5.6% |
| Revenue YoY | 23.7% | 9.0% |
| Net Profit YoY | -88.5% | -6.7% |
| EPS (diluted) | $0.00 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $273.0M | ||
| Q3 25 | $169.1M | $670.5M | ||
| Q2 25 | $154.7M | $390.5M | ||
| Q1 25 | $125.2M | $351.0M | ||
| Q4 24 | $149.7M | $250.4M | ||
| Q3 24 | $141.5M | $551.3M | ||
| Q2 24 | $126.7M | $318.4M | ||
| Q1 24 | $110.4M | $333.8M |
| Q4 25 | $1.7M | $15.4M | ||
| Q3 25 | $17.3M | $86.9M | ||
| Q2 25 | $-24.4M | $32.9M | ||
| Q1 25 | $-21.7M | $31.6M | ||
| Q4 24 | $14.7M | $16.5M | ||
| Q3 24 | $-6.7M | $81.5M | ||
| Q2 24 | $-15.7M | $38.7M | ||
| Q1 24 | $-48.4M | $45.0M |
| Q4 25 | 85.7% | 20.1% | ||
| Q3 25 | 88.5% | 22.3% | ||
| Q2 25 | 90.2% | 20.4% | ||
| Q1 25 | 90.7% | 22.6% | ||
| Q4 24 | 90.1% | 22.0% | ||
| Q3 24 | 90.6% | 23.9% | ||
| Q2 24 | 91.1% | 22.5% | ||
| Q1 24 | 87.7% | 24.9% |
| Q4 25 | 8.6% | 7.6% | ||
| Q3 25 | 20.3% | 16.9% | ||
| Q2 25 | -6.1% | 11.2% | ||
| Q1 25 | -6.3% | 11.6% | ||
| Q4 24 | 10.7% | 8.7% | ||
| Q3 24 | 15.3% | 19.7% | ||
| Q2 24 | 11.8% | 16.2% | ||
| Q1 24 | -25.1% | 17.6% |
| Q4 25 | 0.9% | 5.6% | ||
| Q3 25 | 10.2% | 13.0% | ||
| Q2 25 | -15.8% | 8.4% | ||
| Q1 25 | -17.3% | 9.0% | ||
| Q4 24 | 9.8% | 6.6% | ||
| Q3 24 | -4.8% | 14.8% | ||
| Q2 24 | -12.4% | 12.2% | ||
| Q1 24 | -43.9% | 13.5% |
| Q4 25 | $0.00 | $0.30 | ||
| Q3 25 | $0.06 | $1.70 | ||
| Q2 25 | $-0.08 | $0.65 | ||
| Q1 25 | $-0.07 | $0.62 | ||
| Q4 24 | $0.05 | $0.32 | ||
| Q3 24 | $-0.02 | $1.59 | ||
| Q2 24 | $-0.05 | $0.76 | ||
| Q1 24 | $-0.16 | $0.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $211.7M |
| Total DebtLower is stronger | $392.7M | $793.2M |
| Stockholders' EquityBook value | $274.2M | $1.8B |
| Total Assets | $949.9M | $3.2B |
| Debt / EquityLower = less leverage | 1.43× | 0.44× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $211.7M | ||
| Q3 25 | $263.8M | $379.2M | ||
| Q2 25 | $231.0M | $189.2M | ||
| Q1 25 | $250.6M | $174.3M | ||
| Q4 24 | $249.9M | $132.0M | ||
| Q3 24 | $249.8M | $481.2M | ||
| Q2 24 | $260.1M | $359.2M | ||
| Q1 24 | $239.6M | $416.2M |
| Q4 25 | $392.7M | $793.2M | ||
| Q3 25 | $392.0M | $802.7M | ||
| Q2 25 | $391.3M | $872.8M | ||
| Q1 25 | $390.7M | $872.5M | ||
| Q4 24 | $390.1M | $806.8M | ||
| Q3 24 | $389.5M | $706.4M | ||
| Q2 24 | $388.9M | $706.1M | ||
| Q1 24 | $388.4M | $705.7M |
| Q4 25 | $274.2M | $1.8B | ||
| Q3 25 | $230.4M | $1.8B | ||
| Q2 25 | $204.3M | $1.7B | ||
| Q1 25 | $193.6M | $1.6B | ||
| Q4 24 | $194.0M | $1.6B | ||
| Q3 24 | $178.8M | $1.6B | ||
| Q2 24 | $132.5M | $1.5B | ||
| Q1 24 | $130.7M | $1.5B |
| Q4 25 | $949.9M | $3.2B | ||
| Q3 25 | $868.8M | $3.1B | ||
| Q2 25 | $815.3M | $3.1B | ||
| Q1 25 | $789.8M | $3.0B | ||
| Q4 24 | $785.0M | $3.0B | ||
| Q3 24 | $786.6M | $2.8B | ||
| Q2 24 | $749.5M | $2.7B | ||
| Q1 24 | $721.8M | $2.6B |
| Q4 25 | 1.43× | 0.44× | ||
| Q3 25 | 1.70× | 0.45× | ||
| Q2 25 | 1.92× | 0.52× | ||
| Q1 25 | 2.02× | 0.53× | ||
| Q4 24 | 2.01× | 0.50× | ||
| Q3 24 | 2.18× | 0.44× | ||
| Q2 24 | 2.93× | 0.47× | ||
| Q1 24 | 2.97× | 0.48× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $-157.0M |
| Free Cash FlowOCF − Capex | $16.0M | $-157.1M |
| FCF MarginFCF / Revenue | 8.6% | -57.5% |
| Capex IntensityCapex / Revenue | 0.2% | 0.0% |
| Cash ConversionOCF / Net Profit | 9.62× | -10.19× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $93.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $-157.0M | ||
| Q3 25 | $35.7M | $256.3M | ||
| Q2 25 | $-26.5M | $15.8M | ||
| Q1 25 | $7.8M | $-19.8M | ||
| Q4 24 | $-3.9M | $-450.0M | ||
| Q3 24 | $-23.0M | $119.2M | ||
| Q2 24 | $22.7M | $-61.7M | ||
| Q1 24 | $-29.7M | $-59.2M |
| Q4 25 | $16.0M | $-157.1M | ||
| Q3 25 | $35.3M | $255.6M | ||
| Q2 25 | $-28.9M | $15.0M | ||
| Q1 25 | $7.5M | $-20.5M | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-23.3M | $118.4M | ||
| Q2 24 | $21.6M | $-62.3M | ||
| Q1 24 | $-31.5M | $-59.8M |
| Q4 25 | 8.6% | -57.5% | ||
| Q3 25 | 20.9% | 38.1% | ||
| Q2 25 | -18.7% | 3.8% | ||
| Q1 25 | 6.0% | -5.8% | ||
| Q4 24 | -2.8% | — | ||
| Q3 24 | -16.5% | 21.5% | ||
| Q2 24 | 17.0% | -19.6% | ||
| Q1 24 | -28.5% | -17.9% |
| Q4 25 | 0.2% | 0.0% | ||
| Q3 25 | 0.2% | 0.1% | ||
| Q2 25 | 1.6% | 0.2% | ||
| Q1 25 | 0.2% | 0.2% | ||
| Q4 24 | 0.2% | 0.0% | ||
| Q3 24 | 0.3% | 0.1% | ||
| Q2 24 | 0.9% | 0.2% | ||
| Q1 24 | 1.6% | 0.2% |
| Q4 25 | 9.62× | -10.19× | ||
| Q3 25 | 2.06× | 2.95× | ||
| Q2 25 | — | 0.48× | ||
| Q1 25 | — | -0.63× | ||
| Q4 24 | -0.27× | -27.27× | ||
| Q3 24 | — | 1.46× | ||
| Q2 24 | — | -1.59× | ||
| Q1 24 | — | -1.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
